---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-041030"
form_type: "8-K"
ticker: "FRMM"
cik: "0001690080"
company_name: "FORUM MARKETS Inc"
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T06:24:27.430992+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# 180 Life Sciences CEO James Woody resigns; Blair Jordan named Interim CEO

## Summary
- CEO James Woody resigned May 7; receives $50K cash, 25K fully-vested shares, contingency bonus of $50K.
- CSO Jonathan Rothbard resigned; gets $200 cash, then consulted at $150/hr for 6 months.
- Executive Chairman Lawrence Steinman forgave all accrued compensation; stepped down to board member.
- Blair Jordan appointed Interim CEO via consulting firm at $216K/yr plus $250K change-of-control bonus.
- Board set non-executive comp: $50K annual retainer, $15K committee chair, $25K for Strategy Committee.

## SEC filing metadata
- accession: 0001213900-24-041030
- form_type: 8-K
- ticker: FRMM
- cik: 0001690080
- company_name: FORUM MARKETS Inc
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 5.02, 1.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1690080/000121390024041030/0001213900-24-041030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1690080/000121390024041030/ea0205589-8k_180lifesci.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-041030
- JSON: https://secwatch.observer/filing/0001213900-24-041030.json
- Plain text: https://secwatch.observer/filing/0001213900-24-041030.txt

## Key facts
- Executive change
  Dr. Jonathan Rothbard resigned as Chief Scientific Officer at FORUM MARKETS Inc.
  - Action: resigned
  - Role: Chief Scientific Officer
  source text: On May 7, 2024, Dr. Jonathan Rothbard resigned as Chief Scientific Officer of the Company effective the same date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390024041030/0001213900-24-041030-index.htm
- Executive change
  Dr. James N. Woody resigned as Chief Executive Officer (Principal Executive Officer) at FORUM MARKETS Inc.
  - Action: resigned
  - Role: Chief Executive Officer (Principal Executive Officer)
  source text: On May 7, 2024, Dr. James N. Woody resigned as Chief Executive Officer (Principal Executive Officer), and as a member of the Board of Directors, of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”) effective the same date
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390024041030/0001213900-24-041030-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.